CompaniesRaptor Pharmaceuticals

Raptor Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

169

By Phase

PHASE2/PHASE3: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2011

2012

2013

2014

2015

2016

Today

Hover over trial bars to see details

Recent Trials

NCT01529268Collaborator

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

PHASE2/PHASE3Completed

169 participants

Started: Jun 30, 2012 · Completed: Sep 30, 2015

Funding History (17)

8-K

Oct 6, 2009

D

Sep 16, 2009

DEF 14A

Aug 31, 2009

8-K

Aug 31, 2009

8-K

Aug 25, 2009

8-K

Jul 31, 2009

8-K

Jul 28, 2009

8-K

Jul 24, 2009

8-K

Jun 23, 2009

8-K

Jun 9, 2009

Related Companies

Horizon Pharma

acquired